Eric Gegg
Urology · Columbia, MONPI 1558046011
Payments from drug & device makers
Across 71 payments — averaging $51.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Astellas Pharma US Inc$461
- Medical Device Business Services, Inc.$413
- Medtronic$236
- Coloplast$224
- Merck$171
- plus $636 from 16 others
What the payments were for
- Food & beverage$2,81178%
- Education$81322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $1,483 |
| Astellas Pharma US Inc | 7 | $461 |
| Medical Device Business Services, Inc. | 2 | $413 |
| Medtronic | 8 | $236 |
| Coloplast | 3 | $224 |
| Merck | 5 | $171 |
| Urogen Pharma, Inc. | 2 | $131 |
| Teleflex LLC | 3 | $106 |
| Ferring Pharmaceuticals Inc. | 2 | $60 |
| Olympus America Inc. | 1 | $37 |
| Convatec Inc. | 2 | $36 |
| Johnson & Johnson(2 entities) | 2 | $34 |
| ABC Home Medical Supply, Inc. | 2 | $33 |
| Laborie Medical Technologies Corp. | 1 | $27 |
| Axonics, Inc. | 1 | $27 |
| Edwards Lifesciences | 1 | $24 |
| Vertex | 1 | $24 |
| 180 Medical, Inc. | 1 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| KARL Storz Endoscopy-america | 1 | $19 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700 CXR RTE KIT$449
- LithoVue$285
- TITAN$121
- AMS 700$108
How this compares
$3,623 in reported general payments places this provider in the 45th percentile of 250 urology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 23 | $13,495 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 15 | $416 |
| Finasteride | 25 | $347 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $183 |
| Oxycodone Hcl | 56 | $138 |
| Tamsulosin Hcl | 13 | $116 |
| Cyclobenzaprine Hcl | 22 | $85 |
| Ciprofloxacin Hcl | 23 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $461 | $13,49523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 250 urology providers in Missouri.
Other urology in Columbia
- Mark WakefieldColumbia$122K
- Jack CampbellColumbia$54K
- Eliza DefrodaColumbia$18K
- Julie RileyColumbia$10K
- Travis BullockSaint Louis$751K
- Michael JohnsonSaint Louis$471K
- Gregory AuffenbergSaint Louis$468K
- Gerald AndrioleSaint Louis$308K
- Hing LaiSaint Louis$173K
- Samuel KuykendallKansas City$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.